✦ LIBER ✦

Chronic administration of DSP-7238, a novel, potent, specific and substrate-selective DPP IV inhibitor, improves glycaemic control and β-cell damage in diabetic mice

✍ Scribed by Y. Furuta; M. Horiguchi; E. Sugaru; M. Ono-Kishino; M. Otani; M. Sakai; Y. Masui; A. Tsuchida; Y. Sato; K. Takubo; H. Hochigai; H. Kimura; H. Nakahira; T. Nakagawa; M. Taiji

Book ID: 109044937
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 811 KB
Volume: 12
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2009.01180.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic administration of alogliptin, a

Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice

✍ Yusuke Moritoh; Koji Takeuchi; Tomoko Asakawa; Osamu Kataoka; Hiroyuki Odaka 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 808 KB